Henri Lachmann, chairman of the supervisory board of Schneider Electric, has joined the board of directors of Carmat SAS, a French company that has developed an experimental, artificial heart for patients with heart failure. Mr Lachmann is also chairman of the board of the Marie Lannelongue Surgical Centre near Paris. The surgical centre invested in Carmat when the company floated its shares on the Paris stock exchange in July 2010. Carmat was founded in 2008 by Professor Alain Carpentier, a prominent heart surgeon; by Truffle Capital and by the European Aeronautic, Defence and Space Agency in order to provide a novel treatment for patients for whom standard drug therapy, ventricular assistance and/or heart transplant has failed or is not possible.
Copyright 2010 Evernow Publishing Ltd